Sunday, February 21, 2021 4:17:15 PM
In all the expected trials, CV included, Brilacidin is being tested at dosages below, or equal, to those given in prior trials where no safety issues were encountered. So why would one expect safety problems now?
In terms of efficacy, especially for CV, with an SI of 426 how can one expect anything but success with an extremely high level of confidence? If it doesn't do great, than the SI used by medicine is an absolute joke and doesn't mean squat. So are you saying you think the SI is just pure BS?
Is there risk, yes, but "high, high" risk? In my opinion, no.
I know we differ in viewpoint and I respect yours, but I tend to believe you are viewing Brilacidin as the same kind of drug you have seen tested in years past where they really didn't know squat about it prior to the trials. The many years of using computational screening IMO makes Brilacidin a whole new animal of drug.
Kind of like the recent landing on Mars, could this have been done years ago without the computer power we now possess to limit the odds of failure? Same thing with our drug compared to prior drugs.
Hope I am right on this subject so we both succeed in our investment.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM